Northwestern Mutual Wealth Management Co. Sells 123,236 Shares of Kenvue Inc. $KVUE

Northwestern Mutual Wealth Management Co. trimmed its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 60.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 82,225 shares of the company’s stock after selling 123,236 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Kenvue were worth $1,418,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of KVUE. Physician Wealth Advisors Inc. boosted its holdings in shares of Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after buying an additional 618 shares in the last quarter. Elyxium Wealth LLC bought a new position in shares of Kenvue during the 4th quarter worth approximately $26,000. SBI Securities Co. Ltd. boosted its holdings in shares of Kenvue by 82.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock worth $39,000 after buying an additional 1,027 shares in the last quarter. Atlantic Union Bankshares Corp boosted its holdings in shares of Kenvue by 184.1% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 2,619 shares of the company’s stock worth $43,000 after buying an additional 1,697 shares in the last quarter. Finally, Leonteq Securities AG bought a new position in shares of Kenvue during the 4th quarter worth approximately $45,000. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

KVUE has been the topic of a number of research analyst reports. Argus upgraded Kenvue to a “hold” rating in a report on Friday, March 6th. Zacks Research upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Weiss Ratings cut Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 29th. UBS Group cut their target price on Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. Finally, Canaccord Genuity Group increased their target price on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $19.33.

Insider Buying and Selling

In related news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.59% of the company’s stock.

Kenvue Price Performance

Shares of KVUE opened at $17.72 on Monday. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $22.87. The business’s fifty day moving average is $17.37 and its 200 day moving average is $17.48. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. The stock has a market cap of $34.01 billion, a P/E ratio of 20.84, a P/E/G ratio of 1.34 and a beta of 0.54.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. During the same period last year, the business earned $0.24 EPS. Kenvue’s quarterly revenue was up 4.5% compared to the same quarter last year. Sell-side analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is currently 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.